| JPM JAPAN STRATEGIC VALUE A (ACC) EUR | RVI JAPÓN VALOR | 40,57% | 86,69% | 96,65% | 186,75% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 61,85% | 96,72% | 96,60% | 331,53% |
| JPM EUROPE STRATEGIC DIVIDEND I2 (ACC) EUR | RVI EUROPA VALOR | 31,48% | 86,06% | 96,57% | · |
| MUTUAFONDO TECNOLOGICO, FI A | RVI TECNOLOGÍA | 37,17% | 93,19% | 96,53% | 413,44% |
| CAPITAL GROUP INVESTMENT COMPANY OF AMERICA (LUX) A7 USD | RVI USA | 17,90% | 69,69% | 96,50% | · |
| GAM MULTISTOCK JAPAN SPECIAL SITUATIONS B CHF HEDGED | RENT. ABSOLUTA. | 39,32% | 61,34% | 96,49% | 214,29% |
| JANUS HENDERSON HF - EUROLAND I2 USD HEDGED | RV EURO | 27,75% | 68,38% | 96,46% | 212,04% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 60,85% | 97,35% | 96,46% | 331,67% |
| COMGEST GROWTH JAPAN USD I H ACC | RVI JAPÓN CRECIMIENTO | 41,33% | 89,77% | 96,44% | · |
| INVESCO EMERGING MARKETS EX-CHINA EQUITY C CAP USD | RVI ASIA PACÍFICO | 57,48% | 85,05% | 96,40% | · |
